If you have suffered from depression and tried two or more antidepressants in your current episode without adequate relief, you might suffer from treatment-resistant depression.

SPRAVATO^®  (esketamine) is the first nasal spray medication approved by the Food and Drug Administration, taken along with an oral antidepressant, for adults with treatment-resistant depression, and depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior.

My office is a certified SPRAVATO^® treatment center and I am very excited to provide this new service to my patients.   Please call my office for more information about this effective new medication for treatment-resistant depression and suicidal thoughts and behavior.

Also, more information is available at www.spravato.com